Additional Information

Description

Bupivacaine HCl 125 mg MDV 50 mL is a pharmaceutical product manufactured by MEITHEAL PHARMACEUTICALS INC. It is primarily utilized for its potent local anesthetic properties, commonly administered via intravenous injection. This formulation is designed to provide effective pain relief by blocking nerve impulses in a localized area, making it particularly useful in surgical procedures requiring prolonged anesthesia or post-operative pain management.

The medication's active ingredient, Bupivacaine hydrochloride, acts by inhibiting sodium ion influx through sodium channels in nerve membranes. This mechanism of action results in reversible blockade of nerve conduction, thereby preventing the initiation and transmission of nerve impulses. The onset of action is typically rapid, with effects lasting several hours, depending on the dose and administration technique used.

As with all pharmaceuticals, Bupivacaine HCl 125 mg MDV 50 mL must be handled and administered with care according to medical guidelines to minimize risks of systemic toxicity or adverse reactions. It is crucial for healthcare professionals to monitor patients closely during and after administration, ensuring proper dosing and management of any potential side effects. Proper storage conditions, such as room temperature storage, are recommended to maintain the integrity and efficacy of the product until use.